BBIO
NASDAQ · Biotechnology
Bridgebio Pharma Inc
$74.29
+0.02 (+0.03%)
Performance
1D
+0.00%
1W
-0.94%
1M
+14.22%
3M
-12.26%
6M
+14.86%
1Y
+20.21%
YTD
-5.04%
Open$74.21
Previous Close$74.27
Day High$75.70
Day Low$73.19
52W High$93.42
52W Low$60.55
Volume—
Avg Volume3.48M
Market Cap14.51B
P/E Ratio—
EPS$-2.91
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$69.76
Above
SMA 200
$72.68
Above
RSI (14)
68.4
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
29 analysts
Price Target
+155.8% upside
Current
$74.29
$74.29
Target
$190.06
$190.06
$141.92
$190.06 avg
$243.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 512.09M | 274.88M | 2.34B |
| Net Income | -739,405,176 | -357,200,568 | -436,239,166 |
| Profit Margin | -144.4% | -137.2% | -18.6% |
| EBITDA | -549,894,750 | -280,407,950 | -548,703,476 |
| Free Cash Flow | — | — | -421,297,535 |
| Rev Growth | +86.3% | +86.3% | -0.2% |
| Debt/Equity | 8.27 | 8.27 | 0.84 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |